176 related articles for article (PubMed ID: 22492689)
21. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
22. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.
Francis JH; Levin AM; Zabor EC; Gobin YP; Abramson DH
PLoS One; 2018; 13(5):e0197081. PubMed ID: 29791475
[TBL] [Abstract][Full Text] [Related]
23. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
[TBL] [Abstract][Full Text] [Related]
25. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
26. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
[TBL] [Abstract][Full Text] [Related]
27. Outcome of interventional treatment modalities for retinoblastoma: Experience at a tertiary care centre in Pakistan.
Mian LS; Aqil A; Abid K; Moin M
J Pak Med Assoc; 2019 Jul; 69(7):1039-1043. PubMed ID: 31983743
[TBL] [Abstract][Full Text] [Related]
28. Rhegmatogenous retinal detachment after treatment of retinoblastoma.
Bovey EH; Fernandez-Ragaz A; Héon E; Balmer A; Munier FL
Ophthalmic Genet; 1999 Sep; 20(3):141-51. PubMed ID: 10520235
[TBL] [Abstract][Full Text] [Related]
29. Rhegmatogenous retinal detachment following treatment for retinoblastoma.
Saumya Pal S; Gopal L; Khetan V; Nagpal A; Sharma T
J Pediatr Ophthalmol Strabismus; 2010; 47(6):349-55. PubMed ID: 20055334
[TBL] [Abstract][Full Text] [Related]
30. Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors.
Abramson DH; Francis JH; Dunkel IJ; Marr BP; Brodie SE; Gobin YP
Ophthalmology; 2013 Mar; 120(3):560-565. PubMed ID: 23177361
[TBL] [Abstract][Full Text] [Related]
31. Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma.
Qureshi AM; Davies LK; Patel PA; Rennie A; Robertson F
AJNR Am J Neuroradiol; 2019 Apr; 40(4):713-717. PubMed ID: 30872423
[TBL] [Abstract][Full Text] [Related]
32. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
33. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
34. Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.
Boddu SR; Abramson DH; Marr BP; Francis JH; Gobin YP
J Neurointerv Surg; 2017 Nov; 9(11):1107-1112. PubMed ID: 29030462
[TBL] [Abstract][Full Text] [Related]
35. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Jabbour P; Shields JA
Retina; 2012 Apr; 32(4):799-804. PubMed ID: 22105496
[TBL] [Abstract][Full Text] [Related]
36. Thrombophilia in patients with retinoblastoma receiving ophthalmic artery chemosurgery.
Francis JH; Gobin YP; Nagiel A; Dunkel IJ; Kucine N; Marr BP; Brodie SE; Abramson DH
Arch Ophthalmol; 2012 Dec; 130(12):1605-8. PubMed ID: 23229706
[No Abstract] [Full Text] [Related]
37. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
38. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
[TBL] [Abstract][Full Text] [Related]
39. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
[TBL] [Abstract][Full Text] [Related]
40. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
